Share Price and Basic Stock Data
Last Updated: December 31, 2025, 8:37 pm
| PEG Ratio | -13.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uravi Defence & Technology Ltd operates in the auto ancillary sector, focusing on equipment lamps. As of September 2025, the company’s share price stood at ₹188, with a market capitalization of ₹213 Cr. The company recorded sales of ₹43.63 Cr for the year ending March 2025, with a trailing twelve-month (TTM) figure of ₹43.51 Cr. Quarterly revenue trends show variability, with sales peaking at ₹12.07 Cr in September 2025, in contrast to a low of ₹10.02 Cr in December 2024 and June 2025. This fluctuation indicates potential seasonality or changes in market demand. The operating profit margin (OPM) for the same quarter was reported at a mere 5.14%, reflective of increasing operational costs or pricing pressures. Over the periods analyzed, the total sales exhibited a modest growth trajectory, but the company’s ability to consistently enhance revenue will be critical for future performance.
Profitability and Efficiency Metrics
Profitability metrics reveal challenges for Uravi Defence & Technology Ltd. The net profit for the year ending March 2025 was ₹2.55 Cr, translating to a net profit margin of 4.46%. This figure is relatively low when compared to typical sector benchmarks, indicating pressure on profitability. The company’s operating profit stood at ₹5.78 Cr, with an operating profit margin of 13.25%, which is commendable but below the potential seen in the sector. The cash conversion cycle (CCC) was reported at 511.92 days, a concerning figure that reflects inefficiencies in managing inventory and receivables. Inventory days were particularly high at 453.33, suggesting that the company may face challenges in moving its products efficiently. These metrics collectively highlight the need for improved operational efficiency to enhance profitability.
Balance Sheet Strength and Financial Ratios
As of September 2025, Uravi Defence & Technology Ltd reported total assets of ₹90.13 Cr against liabilities of ₹90.13 Cr, indicating a balanced sheet with no net asset leverage. The company’s reserves stood at ₹38.98 Cr, providing a cushion for future growth initiatives. Borrowings were recorded at ₹25.71 Cr, which corresponds to a total debt to equity ratio of 0.55, indicating a moderate level of leverage. The interest coverage ratio (ICR) was robust at 3.54 times, suggesting that the company can comfortably meet interest obligations. However, the price-to-book value ratio was high at 8.52x, indicating that the stock might be overvalued relative to its book value. This could deter value-focused investors, despite the company’s stable financial position. The current ratio of 1.90 shows good short-term liquidity, but the overall financial health suggests a need for cautious management of liabilities.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uravi Defence & Technology Ltd indicates a significant shift in promoter holdings. Promoter ownership declined from 72.73% in March 2023 to 58.39% by September 2025, reflecting a possible dilution of control or a strategic decision to attract institutional investment. Foreign Institutional Investors (FIIs) increased their stake from 0% in March 2023 to 8.24% by September 2025, indicating growing confidence in the company’s prospects. The public shareholding rose to 33.38%, suggesting a growing interest among retail investors, with the number of shareholders increasing from 1,936 in March 2025 to 3,133 by September 2025. This diversification of ownership may enhance liquidity but could also lead to volatility if investor sentiment shifts. The gradual increase in public and institutional holdings reflects a cautious optimism about Uravi’s future performance.
Outlook, Risks, and Final Insight
Looking ahead, Uravi Defence & Technology Ltd faces both opportunities and risks. The potential for revenue growth exists, given the increasing public interest and rising FII investments. However, the company must address its operational inefficiencies highlighted by the high cash conversion cycle and substantial inventory days to improve profitability. Additionally, the declining promoter stake may raise concerns about control and direction, which could affect investor sentiment. On the risk front, external economic factors such as raw material price volatility and market competition could impact margins. If the company can streamline operations and enhance its product offerings, it may solidify its market position. Conversely, failure to manage costs and maintain profitability could hinder growth and investor confidence. The path forward will require diligent management and strategic execution to navigate these challenges effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 9,033 Cr. | 591 | 695/365 | 46.6 | 110 | 0.17 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 213 Cr. | 188 | 588/153 | 104 | 44.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 4,874 Cr. | 5,218 | 5,870/1,960 | 32.6 | 873 | 0.67 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,950 Cr. | 2,260 | 2,445/1,156 | 26.5 | 410 | 1.33 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 5,017.50 Cr | 2,064.25 | 52.43 | 359.30 | 0.54% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Sales | 11.12 | 10.02 | 11.40 | 10.02 | 12.07 |
| Expenses | 9.62 | 9.08 | 9.65 | 8.80 | 11.45 |
| Operating Profit | 1.50 | 0.94 | 1.75 | 1.22 | 0.62 |
| OPM % | 13.49% | 9.38% | 15.35% | 12.18% | 5.14% |
| Other Income | 0.07 | 0.37 | 0.33 | 0.40 | 0.27 |
| Interest | 0.57 | 0.40 | 0.39 | 0.39 | 0.38 |
| Depreciation | 0.55 | 0.55 | 0.51 | 0.52 | 0.48 |
| Profit before tax | 0.45 | 0.36 | 1.18 | 0.71 | 0.03 |
| Tax % | 33.33% | 25.00% | 31.36% | 25.35% | 233.33% |
| Net Profit | 0.35 | 0.71 | 0.93 | 0.53 | -0.05 |
| EPS in Rs | 0.32 | 0.65 | 0.75 | 0.38 | 0.07 |
Last Updated: December 28, 2025, 4:33 pm
Below is a detailed analysis of the quarterly data for Uravi Defence & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 12.07 Cr.. The value appears strong and on an upward trend. It has increased from 10.02 Cr. (Jun 2025) to 12.07 Cr., marking an increase of 2.05 Cr..
- For Expenses, as of Sep 2025, the value is 11.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.80 Cr. (Jun 2025) to 11.45 Cr., marking an increase of 2.65 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.62 Cr.. The value appears to be declining and may need further review. It has decreased from 1.22 Cr. (Jun 2025) to 0.62 Cr., marking a decrease of 0.60 Cr..
- For OPM %, as of Sep 2025, the value is 5.14%. The value appears to be declining and may need further review. It has decreased from 12.18% (Jun 2025) to 5.14%, marking a decrease of 7.04%.
- For Other Income, as of Sep 2025, the value is 0.27 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Jun 2025) to 0.27 Cr., marking a decrease of 0.13 Cr..
- For Interest, as of Sep 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.39 Cr. (Jun 2025) to 0.38 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.52 Cr. (Jun 2025) to 0.48 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.71 Cr. (Jun 2025) to 0.03 Cr., marking a decrease of 0.68 Cr..
- For Tax %, as of Sep 2025, the value is 233.33%. The value appears to be increasing, which may not be favorable. It has increased from 25.35% (Jun 2025) to 233.33%, marking an increase of 207.98%.
- For Net Profit, as of Sep 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.53 Cr. (Jun 2025) to -0.05 Cr., marking a decrease of 0.58 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 0.38 (Jun 2025) to 0.07, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 43.63 | 43.51 |
| Expenses | 37.85 | 38.98 |
| Operating Profit | 5.78 | 4.53 |
| OPM % | 13.25% | 10.41% |
| Other Income | 0.97 | 1.37 |
| Interest | 1.91 | 1.56 |
| Depreciation | 2.05 | 2.06 |
| Profit before tax | 2.79 | 2.28 |
| Tax % | 30.11% | |
| Net Profit | 2.55 | 2.12 |
| EPS in Rs | 2.18 | 1.85 |
| Dividend Payout % | 0.00% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 44% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 11.26 | 11.36 |
| Reserves | 35.10 | 38.98 |
| Borrowings | 25.88 | 25.71 |
| Other Liabilities | 16.53 | 14.08 |
| Total Liabilities | 88.77 | 90.13 |
| Fixed Assets | 19.58 | 19.26 |
| CWIP | 2.71 | 2.78 |
| Investments | 0.19 | 8.98 |
| Other Assets | 66.29 | 59.11 |
| Total Assets | 88.77 | 90.13 |
Below is a detailed analysis of the balance sheet data for Uravi Defence & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.36 Cr.. The value appears strong and on an upward trend. It has increased from 11.26 Cr. (Mar 2025) to 11.36 Cr., marking an increase of 0.10 Cr..
- For Reserves, as of Sep 2025, the value is 38.98 Cr.. The value appears strong and on an upward trend. It has increased from 35.10 Cr. (Mar 2025) to 38.98 Cr., marking an increase of 3.88 Cr..
- For Borrowings, as of Sep 2025, the value is 25.71 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.88 Cr. (Mar 2025) to 25.71 Cr., marking a decrease of 0.17 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.08 Cr.. The value appears to be improving (decreasing). It has decreased from 16.53 Cr. (Mar 2025) to 14.08 Cr., marking a decrease of 2.45 Cr..
- For Total Liabilities, as of Sep 2025, the value is 90.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.26 Cr.. The value appears to be declining and may need further review. It has decreased from 19.58 Cr. (Mar 2025) to 19.26 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 2.78 Cr.. The value appears strong and on an upward trend. It has increased from 2.71 Cr. (Mar 2025) to 2.78 Cr., marking an increase of 0.07 Cr..
- For Investments, as of Sep 2025, the value is 8.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 8.98 Cr., marking an increase of 8.79 Cr..
- For Other Assets, as of Sep 2025, the value is 59.11 Cr.. The value appears to be declining and may need further review. It has decreased from 66.29 Cr. (Mar 2025) to 59.11 Cr., marking a decrease of 7.18 Cr..
- For Total Assets, as of Sep 2025, the value is 90.13 Cr.. The value appears strong and on an upward trend. It has increased from 88.77 Cr. (Mar 2025) to 90.13 Cr., marking an increase of 1.36 Cr..
Notably, the Reserves (38.98 Cr.) exceed the Borrowings (25.71 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2025 |
|---|---|
Free Cash Flow
| Month | Mar 2025 |
|---|---|
| Free Cash Flow | -20.10 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2025 |
|---|---|
| Debtor Days | 119.97 |
| Inventory Days | 453.33 |
| Days Payable | 61.37 |
| Cash Conversion Cycle | 511.92 |
| Working Capital Days | 122.81 |
| ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 2.31 |
| Diluted EPS (Rs.) | 2.25 |
| Cash EPS (Rs.) | 3.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.18 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.18 |
| Revenue From Operations / Share (Rs.) | 38.75 |
| PBDIT / Share (Rs.) | 5.99 |
| PBIT / Share (Rs.) | 4.17 |
| PBT / Share (Rs.) | 2.48 |
| Net Profit / Share (Rs.) | 1.73 |
| NP After MI And SOA / Share (Rs.) | 2.18 |
| PBDIT Margin (%) | 15.46 |
| PBIT Margin (%) | 10.76 |
| PBT Margin (%) | 6.39 |
| Net Profit Margin (%) | 4.46 |
| NP After MI And SOA Margin (%) | 5.63 |
| Return on Networth / Equity (%) | 5.30 |
| Return on Capital Employeed (%) | 8.54 |
| Return On Assets (%) | 2.76 |
| Long Term Debt / Equity (X) | 0.02 |
| Total Debt / Equity (X) | 0.55 |
| Current Ratio (X) | 1.90 |
| Quick Ratio (X) | 1.11 |
| Interest Coverage Ratio (X) | 3.54 |
| Interest Coverage Ratio (Post Tax) (X) | 2.02 |
| Enterprise Value (Cr.) | 411.15 |
| EV / Net Operating Revenue (X) | 9.42 |
| EV / EBITDA (X) | 60.94 |
| MarketCap / Net Operating Revenue (X) | 9.05 |
| Price / BV (X) | 8.52 |
| Price / Net Operating Revenue (X) | 9.05 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Uravi Defence & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.18. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.18. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 38.75. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.99. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.17. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.18. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 15.46. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.30. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.55. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.54. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 411.15. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.42. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 60.94. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 8.52. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi Defence & Technology Ltd:
- Net Profit Margin: 4.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.54% (Industry Average ROCE: 20.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.3% (Industry Average ROE: 15.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 104 (Industry average Stock P/E: 52.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | Shop No. 329 Avior, Nirmal Galaxy, Mumbai Maharashtra 400080 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Niraj Damji Gada | Managing Director & CEO |
| Mr. Kaushik Damji Gada | WholeTime Director & CFO |
| Mr. Shlok Kaushik Gada | Whole Time Director |
| Ms. Shreya Ramkrishnan | Ind. Non-Executive Director |
| Mr. Sreedhar Ramachandran Ayalur | Ind. Non-Executive Director |
| Mr. Niken Shah | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Uravi Defence & Technology Ltd?
Uravi Defence & Technology Ltd's intrinsic value (as of 01 January 2026) is ₹562.65 which is 199.28% higher the current market price of ₹188.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹213 Cr. market cap, FY2025-2026 high/low of ₹588/153, reserves of ₹38.98 Cr, and liabilities of ₹90.13 Cr.
What is the Market Cap of Uravi Defence & Technology Ltd?
The Market Cap of Uravi Defence & Technology Ltd is 213 Cr..
What is the current Stock Price of Uravi Defence & Technology Ltd as on 01 January 2026?
The current stock price of Uravi Defence & Technology Ltd as on 01 January 2026 is ₹188.
What is the High / Low of Uravi Defence & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uravi Defence & Technology Ltd stocks is ₹588/153.
What is the Stock P/E of Uravi Defence & Technology Ltd?
The Stock P/E of Uravi Defence & Technology Ltd is 104.
What is the Book Value of Uravi Defence & Technology Ltd?
The Book Value of Uravi Defence & Technology Ltd is 44.2.
What is the Dividend Yield of Uravi Defence & Technology Ltd?
The Dividend Yield of Uravi Defence & Technology Ltd is 0.00 %.
What is the ROCE of Uravi Defence & Technology Ltd?
The ROCE of Uravi Defence & Technology Ltd is %.
What is the ROE of Uravi Defence & Technology Ltd?
The ROE of Uravi Defence & Technology Ltd is %.
What is the Face Value of Uravi Defence & Technology Ltd?
The Face Value of Uravi Defence & Technology Ltd is 10.0.